[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot
J C
JC
Centre Georges-François-Leclerc, Dijon, France.
Bontemps
P
P
Begg
A C
AC
Le Fur
R
R
Van den Bogaert
W
W
Bolla
M
M
N'Guyen
T
T
Van den Weijngaert
D
D
Bernier
J
J
Lusinchi
A
A
Stuschke
D
D
Lopez Torrecilla
D
D
Jancar
B
B
Collette
L
L
Van Glabbeke
M
M
Pierart
M
M
D000206:Actuarial Analysis; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000532:radiotherapy*; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D009367:Neoplasm Staging; D009959:Oropharyngeal Neoplasms / Q000473:pathology / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D011879:Radiotherapy Dosage; D015996:Survival Rate; D013997:Time Factors
Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique.